Chandra Bhagat Pharma Ltd - Stock Valuation and Financial Performance

BSE: 542934 | NSE: | Pharmaceuticals & Drugs | Small Cap

Chandra Bhagat Pharm Share Price

95 0.00 0.00%
as on 27-Mar'24 16:01

DeciZen - make an informed investing decision on Chandra Bhagat Pharm

M-Cap below 100cr DeciZen not available

Chandra Bhagat Pharma stock performance -

mw4me loader
P/E Ratio (SA):
79.17
Market Cap:
71.7 Cr.
52-wk low:
80
52-wk high:
160

Is Chandra Bhagat Pharma Ltd an attractive stock to invest in?

1. Is Chandra Bhagat Pharma Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chandra Bhagat Pharma Ltd is a below average quality company.

2. Is Chandra Bhagat Pharma Ltd undervalued or overvalued?

The key valuation ratios of Chandra Bhagat Pharma Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Chandra Bhagat Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chandra Bhagat Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Chandra Bhagat Pharm:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Chandra Bhagat Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 8.5%7.1%8.4%13.2%12.6%9.5%5.2%5.7%7.4%5.3%-
Value Creation
Index
-0.4-0.5-0.4-0.1-0.1-0.3-0.6-0.6-0.5-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4861.179.889.897.11069470.794.1120120
Sales YoY Gr.-27.3%30.6%12.5%8.1%9.5%-11.6%-24.8%33.1%27.2%-
Adj EPS 8.410.28.453.61.40.60.61.91.31.2
YoY Gr.-20.9%-18%-39.8%-29.4%-61.4%-58.4%1.8%231%-34.4%-
BVPS (₹) 142.8153161.522.223.824.932.232.533.735.235.2
Adj Net
Profit
0.40.40.41.71.20.70.40.41.511
Cash Flow from Ops. 000-9-6.24.1-7.48.312.45.3-
Debt/CF from Ops. 000-2.5-3.57.7-43.31.73.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.7%4.3%8.4%27.2%
Adj EPS -19%-18.7%30.3%-34.4%
BVPS-14.4%8.1%3%4.4%
Share Price - - 33.9% -1.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
7.56.95.323.8156.42.11.75.53.53.4
Op. Profit
Mgn %
3.84.95.46.55.14.43.55.73.92.7NAN
Net Profit
Mgn %
0.70.70.41.91.20.70.50.61.50.80.8
Debt to
Equity
3.14.34.432.72.31.21.10.80.7-
Working Cap
Days
1761881721811982272893602561790
Cash Conv.
Cycle
1161391301211221331632021611220

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 30.27%

Debt to equity has declined versus last 3 years average to 0.71

Return on Equity has declined versus last 3 years average to 3.40%

Sales growth has been subdued in last 3 years 8.39%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Chandra Bhagat Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 1.2 -
TTM Sales (₹ Cr.) 120 -
BVPS (₹.) 35.2 -
Reserves (₹ Cr.) 20 -
P/BV 2.70 -
PE 79.17 -
From the Market
52 Week Low / High (₹) 80.00 / 160.00
All Time Low / High (₹) 30.50 / 160.00
Market Cap (₹ Cr.) 71.7
Equity (₹ Cr.) 7.6
Face Value (₹) 10
Industry PE 47.8

Management X-Ray of Chandra Bhagat Pharm:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Chandra Bhagat Pharm

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales48.0161.1379.8489.7997.06106.2893.9870.7094.08119.67
Operating Expenses 46.1958.1475.5685.4292.47101.6990.8667.0191.33116.49
Manufacturing Costs000.140.150.130.310.140.240.340.70
Material Costs34.8444.7162.9873.6082.3992.3785.8059.7481.36106.58
Employee Cost 5.137.057.315.645.024.532.251.851.521.32
Other Costs 6.226.375.126.024.934.482.665.188.117.89
Operating Profit 1.822.994.294.374.594.593.123.682.753.18
Operating Profit Margin (%) 3.8%4.9%5.4%4.9%4.7%4.3%3.3%5.2%2.9%2.7%
Other Income 0.640.310.390.490.670.440.440.481.620.29
Interest 1.882.353.713.813.674.093.113.763.242.20
Depreciation 0.170.260.240.140.060.050.030.120.040.11
Exceptional Items 0000000000
Profit Before Tax 0.420.690.720.911.530.890.420.281.101.16
Tax 0.070.270.370.250.500.200.110.090.300.26
Profit After Tax 0.350.430.350.661.030.690.310.190.800.91
PAT Margin (%) 0.7%0.7%0.4%0.7%1.1%0.6%0.3%0.3%0.8%0.8%
Adjusted EPS (₹)1.11.31.12.03.11.30.40.31.11.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 5.976.406.757.418.4414.4525.6925.8826.6827.48
Share Capital 0.420.420.420.420.420.677.557.557.557.55
Reserves 5.555.986.336.998.0313.7818.1418.3319.1319.93
Minority Interest0000000000
Debt18.5827.5029.5820.5021.7527.7827.5025.0919.8117.67
Long Term Debt0004.2211.7411.4610.899.455.423.93
Short Term Debt18.5827.5029.5816.2810.0116.3216.6215.6314.3913.74
Trade Payables5.065.295.6616.2715.4829.7012.4912.852.673.10
Others Liabilities 1.913.022.5011.6812.3610.919.067.9623.3112.34
Total Liabilities 31.5242.2044.4955.8758.0482.8474.7471.7872.4660.58

Fixed Assets

Gross Block1.020.870.690.701.231.241.241.261.131.50
Accumulated Depreciation0000.140.720.780.810.840.660.77
Net Fixed Assets1.020.870.690.550.510.460.440.420.470.73
CWIP 0000000000
Investments 0004.641.054.030.7500.220.11
Inventories15.4121.6521.1926.7532.6443.9143.9035.1434.1629.08
Trade Receivables8.5711.8914.4719.6617.8626.3014.0315.42158.19
Cash Equivalents 3.865.054.680.580.550.480.052.825.686.44
Others Assets2.662.743.463.695.427.6615.5717.9816.9316.04
Total Assets 31.5242.2044.4955.8758.0482.8474.7471.7872.4660.58

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 000-9.03-6.184.05-7.418.3312.405.26
PBT 0000.911.530.890.420.281.101.16
Adjustment 0003.173.133.822.693.463.032.29
Changes in Working Capital 000-12.86-10.55-0.18-10.534.688.382.14
Tax Paid 000-0.25-0.28-0.470-0.10-0.11-0.23
Cash Flow From Investing Activity 0000.30-0.36-0.400.050.120.09-0.06
Capex 0000-0.02-0.010-0.02-0.09-0.37
Net Investments 0000000000
Others 0000.31-0.34-0.390.050.140.170.31
Cash Flow From Financing Activity 0007.976.51-3.736.94-6.42-9.62-4.45
Net Proceeds from Shares 000005.3010.93000
Net Proceeds from Borrowing 00011.319.67-5.04-0.93-1.96-5.30-1.58
Interest Paid 000-3.34-3.16-3.99-3.06-3.48-3.08-2.19
Dividend Paid 0000000000
Others 0000000-0.98-1.25-0.68
Net Cash Flow 000-0.75-0.02-0.08-0.432.022.860.76
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)7.536.895.389.3313.446.461.670.783.193.49
ROCE (%)11.6610.412.6214.3417.5813.47.167.638.837.3
Asset Turnover Ratio1.731.661.841.791.71.511.190.961.31.8
PAT to CFO Conversion(x)000-13.68-65.87-23.943.8415.55.78
Working Capital Days
Receivable Days66616069717678765935
Inventory Days98111989711213117120413496
Payable Days62423254708990773510

Chandra Bhagat Pharma Ltd Stock News

Chandra Bhagat Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Chandra Bhagat Pharm on 27-Mar-2024 16:01 is ₹95.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Mar-2024 16:01 the market cap of Chandra Bhagat Pharm stood at ₹71.68.
The latest P/E ratio of Chandra Bhagat Pharm as of 27-Mar-2024 16:01 is 79.17.
The latest P/B ratio of Chandra Bhagat Pharm as of 27-Mar-2024 16:01 is 2.70.
The 52-week high of Chandra Bhagat Pharm is ₹160.0 and the 52-week low is ₹80.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chandra Bhagat Pharm is ₹119.7 ( Cr.) .

About Chandra Bhagat Pharma Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.